Bexobrutideg: A Selective, Catalytic Degrader of Bruton's Tyrosine Kinase Overcomes Inhibitor Resistance and Suppresses Autoantibody-Mediated Disease
Mark Noviski, P Auger, Danielle Bautista, Nivetha Brathaban, Brandon J. Bravo, Robert Cass, Ganesh Cherala, Thomas C. Fung, Stefan Gajewski, Dhwani Haria, Zewen Jiang, Dane E. Karr, Aileen Kelly, Daisuke Kato, Zef A. Könst, , Frederick Cohen
Bexobrutideg is a BTK degrader that overcomes inhibitor resistance and suppresses autoimmune disease by catalytically degrading BTK.
bioRxiv · Aug 4, 2026 · PreprintCancer Biology